Algorithms for the diagnosis and treatment of ulcerative colitis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

About the authors

Sofia S. Belous

A.N. Ryzhikh National Medical Research Center of Coloproctology

Author for correspondence.
Email: Sofiabelous@yandex.ru
ORCID iD: 0000-0003-1180-0524

Cand. Sci. (Med.), Senior Researcher, Department of Inflammatory and Functional Bowel Diseases

Russian Federation, Moscow

B. A. Vykova

A.N. Ryzhikh National Medical Research Center of Coloproctology

Email: Sofiabelous@yandex.ru
ORCID iD: 0000-0003-1697-4670
Russian Federation, Moscow

References

  1. Шелыгин Ю.А., Ивашкин В.Т., Белоусова Е.А. и др. Язвенный колит (К51), взрослые. Колопроктология. 2023;22(1):10-44. [Shelygin Yu.A., Ivashkin V.T., Belousova E.A. et al. Ulcerative colitis (K51), adults. Koloproktologiya=Coloproctology. 2023;22(1):10-44. (In Russ.)]. https://doi.org/10.33878/2073-7556-2023-22-1-10-44
  2. Travis S., Dinesen L. Remission intrials of ulcerative colitis: what does it mean? Pract Gastroenterology. 2010;30:17–20.
  3. Григорьева Г.А., Мешалкина Н.Ю. О проблеме системных проявлений воспалительных заболеваний кишечника. Фарматека. 2011;15:44-49. [Grigorieva G.A., Meshalkina N.Yu. On the problem of systemic manifestations of inflammatory bowel diseases. Pharmateca. 2011;15:44-49. (In Russ.)].
  4. Долгалёв И.В. Язвенный колит: клиника, диагностика, лечение: учебное пособие Томск: Изд-во СибГМУ, 2021. [Dolgalev I.V. Ulcerative colitis: clinical features, diagnostics, treatment: a textbook. Tomsk: Publishing house of Siberian State Medical University, 2021. (In Russ.)].
  5. Бикбавова Г.Р., Ливзан М.А., Турчанинов Д.В., Заставная А.А. Язвенный колит – от предрасполагающих факторов до диагноза. Доказательная гастроэнтерология. 2019;8(4-5):5-10. [Bikbavova G.R., Livzan M.A., Turchaninov D.V., Zastavnaya A.A. Ulcerative colitis: from predisposing factors to diagnosis. Dokazatel’naya gastroenterologiya. 2019;8(4-5):5-10. (In Russ.)]. https://doi.org/10.17116/dokgastro2019804-0515
  6. Travis S.P., Jewell D.P. Ulcerative colitis: clinical presentation and diagnosis. In: Satsangi J., Sutherland L.R, editors. Inflammatory Bowel Diseases. London: Churchill Livingstone. 2003:169–81.
  7. Lucendo A.J., Arias Á., Roncero Ó., Hervías D., et al. Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients. Sao Paulo Med J. 2014;132(3):140-6.
  8. Irwin J.R., Ferguson E., Simms L.A., et al. Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn»s Disease. Dig Dis Sci. 2019 Feb;64(2):503-517.
  9. Cherfane C.E., Gessel L., Cirillo D., et al. Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity. Inflamm Bowel Dis. 2015 Aug;21(8):1769-75.
  10. Feng J.R., Qiu X., Wang F., et al. Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Crohn`s Disease. Gastroenterol Res Pract. 2017. https://doi.org/10.1155/2017/3526460
  11. Yoon J.Y., Park S.J., Hong S.P., et al. Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis. Dig Dis Sci. 2014 Apr;59(4):829-37.
  12. Yamamoto-Furusho J.K., Sánchez-Osorio M., Uribe M. Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis. Ann Hepatol. 2010 Oct-Dec;9(4):397-401.
  13. Archampong E.Q., Harris J., Clark C.G. The absorption and secretion of water and electrolytes across the healthy and the diseased human colonic mucosa measured in vitro. Gut. 1972 Nov;13(11):880-6.
  14. Maharshak N., Arbel Y., Gal-Oz A., et al. Comparative analysis of Bayer wide-range C-reactive protein (wr-CRP) and the Dade-Behring high sensitivity C-reactive protein (hs-CRP) in patients with inflammatory bowel disease. J Dig Dis. 2008 Aug;9(3):140-3.
  15. Weber P., Husemann S., Vielhaber H., et al. Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1999 Apr;28(4):418-422.
  16. Issa M., Vikayapal A., Gracham M.B., et al. Impact of Clostridium difficile in inflammatory bowel disease patients. Clin Gastroenterol Hepatol. 2007;5:345-351.
  17. Rodeman J.F., Dubberke E.R., Reske K.A., et al. Incidence of Clostridium difficile in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339-344.
  18. Issa M., Ananthakrishnan A.N., Binion D.G. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1432-42.
  19. Nguyen G.C., Kaplan G.G., Harris M.L., et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443-50.
  20. Kim J.J., Simpson N., Klipfel N., et al. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci. 2010 Apr;55(4):1059-65. https://dx.doi.org/10.1007/s10620-010-1126-4
  21. Levin A., Yaari S., Stoff R., et al. Diagnosis of Cytomegalovirus Infection during Exacerbation of Ulcerative Colitis. Digestion. 2017;96(3):142-148. https://dx.doi.org/10.1159/000479865
  22. Mogan G.R., et al. Toxic megacolon in ulcerative colitis complicated by pneumomediastinum: report of two cases. Gastroenterology. 1980;79(3):559-562.
  23. Lin W.C., Chang C.W., Chen M.J., et al. Effectiveness of sigmoidoscopy for assessing ulcerative colitis disease activity and therapeutic response. Medicine (Baltimore). 2019 May;98(21):e15748. https://dx.doi.org/10.1097/MD.0000000000015748
  24. Schroeder K.Н., Tremaine W., Ilstrup D.М. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-9.
  25. Annese V., Daperno M., Rutter M.D., et al. European evidence based consensus for endoscopy in inflammatory bowel disease. Journal of Crohn’s and Colitis. 2013;7(12):982-1018.
  26. Tanaka M., Saito H., Fukuda S., et al. Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity. Scand J Gastroenterol. 2000 Mar;35(3):281-6.
  27. Куваев Р., Кашин С., Завьялов Д. Роль колоноскопии в диагностике дисплазии и рака толстой кишки при язвенном колите. Врач. 2016;2:70-76. [Kuvaev R., Kashin S., Zavyalov D. The role of colonoscopy in the diagnosis of dysplasia and colon cancer in ulcerative colitis. Vrach. 2016;2:70-76. (In Russ.)].
  28. Parente F., Greco S., Molteni M., et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Alimentary Pharmacology and Therapeutics. 2003;18:1009-1016.
  29. Baltarowich O.H., Scoutt L.M., Hamper U.M. Nongynecologic findings on pelvic ultrasound: focus on gastrointestinal diseases. Ultrasound Quarterly. 2012;28(2):65-85.
  30. Smith R., Taylor K., Friedman A.B., et al. Systematic Review: Clinical Utility of Gastrointestinal Ultrasound in the Diagnosis, Assessment and Management of Patients With Ulcerative Colitis. J Crohns Colitis. 2020 May 21;14(4):465-479. https://dx.doi.org/10.1093/ecco-jcc/jjz163
  31. Gashin L., Villafuerte-Galvez J., Leffler D.A., et al. Utility of CT in the emergency department in patients with ulcerative colitis. Inflamm Bowel Dis. 2015 Apr;21(4):793-800. https://dx.doi.org/10.1097/MIB.0000000000000321
  32. Милько В.И., Минцер О.П., Топчий Т.В., Корсуновский А.А. Клиническая оценка данных ирригоскопии при неспецифическом язвенном колите. Вестник рентгенологии и радиологии. 1983;5:46-50. [Milko V.I., Mintzer O.P., Topchiy T.V., Korsunovsky A.A. Clinical evaluation of irrigoscopy data in nonspecific ulcerative colitis. Vestnik rentgenologii i radiologii. 1983;5:46-50. (In Russ.)].
  33. Silverberg M., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5–36.
  34. Truelove S., Witts L., et al. Cortisone in ulcerative colitis; final report on a therapeutic trial Br Med J. 1955;2:1041-1048.
  35. Dignass A., Eliakim R., Magro F., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis J Crohns Colitis. 2012 Dec;6(10):965-90. https://dx.doi.org/10.1016/j.crohns.2012.09.003
  36. Sandborn W.J., Sands B.E., Vermeire S., et al. Modified Mayo score versus Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program. Therap Adv Gastroenterol. 2022 Dec 5;15:17562848221136331. https://dx.doi.org/10.1177/17562848221136331
  37. Chen J., Andrews J., Kariyawasam V., et al. IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Review article: acute severe ulcerative colitis – evidence-based consensus statements. Aliment Pharmacol Ther. 2016 Jul;44(2):127-44.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2026 Bionika Media

License URL: https://journals.eco-vector.com/2073-4034/about/editorialPolicies